Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Canada
Deutschland
España
France
Italia
Schweiz (DE)
Suisse (FR)
United Kingdom
United States
Settings
Dynamic quotes
OFF
ON
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
DOW JONES
S&P 500
NASDAQ 100
TSX COMP
NIKKEI 225
»
More Indexes
Currency / Forex
EUR / USD
GBP / USD
USD / JPY
USD / CAD
AUD / USD
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic calendar
Listed companies
Analyst reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit warnings
Appointments
Press Releases
Events
Corporate actions
Financial calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All stock picks
Subscribe
Portfolios
My Portfolio
Virtual portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment style
Yield stocks
Growth stocks
Undervalued Stocks
Investment themes
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Place your bets
Europe's family businesses
Let’s all cycle!
Fintechs
Ageing Population
Top / Flop
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment selections
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Place your bets
Europe's family businesses
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic chart
Financial calendar
Economic calendar
Sector research
Currency converter
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
MarketScreener Homepage
>
Equities
>
Australian Stock Exchange
>
Mayne Pharma Group Limited
MYX
AU000000MYX0
MAYNE PHARMA GROUP LIMITED
(MYX)
Add to my list
Report
End-of-day quote Australian Stock Exchange - 01/25
0.35
AUD
+1.45%
01/06
MAYNE PHARMA
: Launches Pregnancy Prevention Tablets in US
MT
01/06
MAYNE PHARMA
: launches Microgestin 24 FE tablets in the US
PU
01/06
MAYNE PHARMA
: 07/01/2021 Mayne Pharma launches Microgestin® 24 Fe tablets in the United States
PU
Summary
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Other languages
Press Releases
Official Publications
Sector news
All news about MAYNE PHARMA GROUP LIMITED
01/06
MAYNE PHARMA
: Launches Pregnancy Prevention Tablets in US
MT
01/06
MAYNE PHARMA
: launches Microgestin 24 FE tablets in the US
PU
01/06
MAYNE PHARMA
: 07/01/2021 Mayne Pharma launches Microgestin® 24 Fe tablets in th..
PU
2020
MAYNE PHARMA
: Extends Three-Year Bullet Facility
MT
2020
MAYNE PHARMA
: 18/12/2020 Mayne Pharma successfully extends debt facility
PU
2020
MAYNE PHARMA
: successfully extends debt facility
PU
2020
MAYNE PHARMA
: 24/11/2020 2020 AGM Chairman's Address
PU
2020
MAYNE PHARMA
: 24/11/2020 2020 AGM CEO's Speech
PU
2020
MAYNE PHARMA
: 09/11/2020 Mayne Pharma Board Renewal
PU
2020
MAYNE PHARMA
: Board Renewal
PU
2020
MAYNE PHARMA
: New data on Mayne Pharma's TOLSURA presented at IDWeek 2020
AQ
2020
MAYNE PHARMA
: 26/10/2020 New data on Mayne Pharma's TOLSURA presented at IDWeek..
PU
2020
MAYNE PHARMA
: Lapse of rights and AGM Notice of Meeting clarification
PU
2020
MAYNE PHARMA
: 2020 Annual General Meeting
PU
2020
MAYNE PHARMA
: 2020 Corporate Governance Statement
PU
2020
MAYNE PHARMA
: Annual Report to shareholders
PU
2020
Mithra Announces FDA update
AQ
2020
MAYNE PHARMA
: provides update on Women's Health pipeline
AQ
2020
MAYNE PHARMA
: 06/10/2020 Mayne Pharma provides update on Women's Health pipelin..
PU
2020
MAYNE PHARMA
: Appoints Chief Financial Officer
AQ
2020
MAYNE PHARMA
: appoints new CFO
PU
2020
MAYNE PHARMA
: 29/09/2020 Mayne Pharma Appoints Chief Financial Officer
PU
2020
MAYNE PHARMA
: Appendix 4E and Statutory Accounts
PU
2020
MAYNE PHARMA
: 2020 Full Year Media Release
PU
2020
MAYNE PHARMA
: 2020 Full Year Investor Presentation
PU
2020
MAYNE PHARMA
: 21/08/2020 Mayne Pharma FY20 Results Media Release
PU
2020
MAYNE PHARMA
: Announces strategic partnership with novast
AQ
2020
MAYNE PHARMA
: Announces Expansion of US Production Space
AQ
2020
Mithra Announces FDA Filing Acceptance of New Drug Application for Estelle in..
AQ
2020
MAYNE PHARMA
: Announces FDA Filing Acceptance of New Drug Application for E4/DR..
AQ
2020
MAYNE PHARMA
: Toni Nesci named head of Mayne Contract Services and New Website ..
AQ
2020
MAYNE PHARMA
: signs license agreement for contraceptive in Australia
AQ
2020
MAYNE PHARMA
: submits NDA for E4/DRSP to the FDA
AQ
2020
MAYNE PHARMA
: Resignation of group chief financial officer and appointment of i..
AQ
2020
MAYNE PHARMA
: 20/03/2020 Change of CFO and Company Secretary
PU
2020
MAYNE PHARMA
: 2020 Half Year Media Release
PU
2020
MAYNE PHARMA
: Half Yearly Report and Accounts
PU
2020
MAYNE PHARMA
: 2020 Half Year Investor Presentation
PU
2020
MAYNE PHARMA
: 21/02/2020 Mayne Pharma 2020 Half Year Media Release
PU
2020
MAYNE PHARMA GROUP LIMITED
: half-yearly earnings release
2019
MAYNE PHARMA
: Aspires To Specialisation
AQ
2019
MAYNE PHARMA
: Final Director's Interest Notice
PU
2019
MAYNE PHARMA
: 22/11/2019 2019 AGM CEO's Speech
PU
2019
MAYNE PHARMA
: 22/11/2019 2019 AGM Chairman's Address
PU
2019
MAYNE PHARMA
: 2019 AGM CEO's Speech
PU
2019
MAYNE PHARMA
: 2019 AGM Chairman's Address
PU
2019
MAYNE PHARMA
: 23/10/2019 E4/DRSP contraceptive presented at EU gynecology confe..
PU
2019
MAYNE PHARMA
: E4/DRSP contraceptive presented at EU gynecology conference
PU
2019
MAYNE PHARMA
: Retirement of Director
PU
2019
MAYNE PHARMA
: 21/10/2019 Retirement of Director
PU
2019
MAYNE PHARMA
: 21/10/2019 Notice of Annual General Meeting/Proxy Form
PU
2019
MAYNE PHARMA
: Change of Director's Interest Notice (x2)
PU
2019
MAYNE PHARMA
: 2019 Annual Report
PU
2019
MAYNE PHARMA
: Appendix 4G and Corporate Governance Statement
PU
2019
MAYNE PHARMA
: MYX signs license agreement for novel oral contraceptive
PU
2019
MAYNE PHARMA
: 02/10/2019 Mayne Pharma signs 20-year license agreement for novel..
PU
2019
MAYNE PHARMA
: Lapse of employee options
PU
2019
MAYNE PHARMA
: Appendix 4E and Full Year Statutory Accounts
PU
2019
MAYNE PHARMA
: 2019 Full Year Results Media Release
PU
2019
MAYNE PHARMA
: 2019 Full Year Results Investor Presentation
PU
2019
MAYNE PHARMA
: 23/08/2019 FY19 Results Media Release
PU
2019
MAYNE PHARMA
: Lapse of employee options
PU
2019
MAYNE PHARMA
: market update
PU
2019
MAYNE PHARMA
: investor presentation to Goldmans conference
PU
2019
MAYNE PHARMA
: Half Year Accounts
PU
2019
MAYNE PHARMA
: 2019 Half Year Investor Presentation
PU
2019
MAYNE PHARMA
: 22/02/2019 HY19 Results Media Release
PU
2019
MAYNE PHARMA GROUP LTD
: half-yearly earnings release
2019
MAYNE PHARMA
: announces new indication for Kapanol by TGA
PU
2019
MAYNE PHARMA
: 19/02/2019 Mayne Pharma Announces New Chronic Breathlessness Indi..
PU
2019
MAYNE PHARMA
: Lexette (halobetasol) foam now launched in the US
PU
2019
MAYNE PHARMA
: 13/02/2019 Mayne Pharma Launches Lexette™ (Halobetasol Prop..
PU
2019
MAYNE PHARMA
: Tolsura (SUBA-itraconazole) capsule now launched in the US
PU
2018
MAYNE PHARMA
: MYX extends debt facility and adds receivables facility
PU
2018
MAYNE PHARMA
: 20/12/2018 Mayne Pharma extends debt facility and adds receivable..
PU
1
2
3
Next
Upcoming event on MAYNE PHARMA GROUP LIMITED
02/19/21
Interim 2021 Earnings Release (Projected)
Company calendar
Upcoming sector events
01/26/21
JOHNSON & JOHNSON
: FY 2020 Earnings Release
01/26/21
NOVARTIS AG
: FY 2020 Earnings Release
01/28/21
LUPIN LIMITED
: Q3 2021 Earnings Release
01/28/21
SUMITOMO DAINIPPON PHARMA CO., LTD.
: Q3 2020 Earnings Release
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals
Master